Thursday, July 9, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Constellation Energy: A 32% Stock Slide Masks Record Revenue and a Nuclear-Led Strategy

Kennethcix by Kennethcix
July 9, 2026
in AI & Quantum Computing, Energy & Oil, Renewable Energy
0
Constellation Energy Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Constellation Energy’s shares have fallen by roughly a third since the start of the year, yet the company just posted a 63.8% jump in quarterly revenue and locked in long-term contracts with technology giants hungry for round-the-clock clean power. The disconnect between operational momentum and market sentiment has left analysts projecting more than 46% upside from current levels, while technical indicators suggest the worst of the selling may be over.

The stock closed at €211.75 on Wednesday, representing a gain of 1.17% over the prior seven days but a year‑to‑date decline of 32.26%. Another recent reading placed the share price at €214.25, with a comparable YTD loss of 31.46%. Either way, the shares trade far below the November 2025 record of €328.70 – a gap of roughly 35.6% – and have only recently built a 5.14% buffer above the 52‑week low touched in early July.

From a technical perspective, the stock remains beneath both its 50‑day moving average of €236.04 and its 100‑day average of €246.90. The relative strength index stands at 38.2, indicating that conditions are no longer overbought and that the selling pressure has been largely exhausted. Buyers have defended the €201.40 support level, which marked the 52‑week trough, suggesting a floor may be forming.

The market’s reluctance to reward Constellation comes despite an accelerating shift toward nuclear power as the preferred baseload source for the U.S. economy. Electricity demand is expected to climb 25% by 2030 and nearly double in the longer term, driven by the expansion of AI data centers and the electrification of transport. Solar and wind alone cannot guarantee the uninterrupted, emission‑free supply that these new consumers require, and policymakers in Washington have taken notice.

The Department of Energy launched the “Speed to Power” program to fast‑track large‑scale generation projects, and Constellation works closely with regulators to bring new capacity online. As the largest U.S. operator of nuclear plants, the company produces roughly 10% of the nation’s carbon‑free electricity. Its existing fleet is a scarce asset: at the start of 2026, the atomic plants achieved a capacity factor of 92.3%, a testament to their reliability.

Should investors sell immediately? Or is it worth buying Constellation Energy?

Constellation’s financial results have underscored the strength of its franchise. In the first quarter of 2026, adjusted earnings per share came in at $2.74, beating analyst expectations. Revenue surged to $11.12 billion, a leap of 63.8% year‑over‑year, largely reflecting the January 2026 closing of the Calpine acquisition. That deal added natural gas and geothermal assets to the portfolio, pushing total capacity to 55 gigawatts.

Management has laid out a clear runway through 2029. For the full year 2026, adjusted operating earnings per share are projected to be between $11.00 and $12.00, and base earnings per share are expected to grow at an annual rate exceeding 20% through the end of the decade. The company’s free cash flow before growth investments is forecast to reach a combined $8.4 billion for 2026 and 2027. Capital expenditures, meanwhile, are set at $5.7 billion for 2026 and $4.7 billion for 2027, with a substantial portion earmarked for nuclear fuel procurement – a move that locks in long‑term supply security for the fleet.

Nevertheless, risks remain. Wholesale electricity prices are volatile, regulatory changes could alter the competitive landscape, and the integration of Calpine’s operations is still underway. These uncertainties help explain why the stock has retreated even as the underlying business gains traction.

For investors willing to look past the near‑term noise, the arithmetic is compelling. Constellation Energy’s market capitalization stands at about €77 billion, and the average analyst price target of €313.62 implies a potential gain of more than 46% from Wednesday’s close. The company’s nuclear reactors – difficult to replicate on any short timeline – are becoming premium assets in a grid strained by surging demand from AI and electric vehicles. If the political tailwinds persist and the U.S. economy’s appetite for clean baseload power continues to grow, the current valuation gap may not stay open for long.

Ad

Constellation Energy Stock: Buy or Sell?! New Constellation Energy Analysis from July 9 delivers the answer:

The latest Constellation Energy figures speak for themselves: Urgent action needed for Constellation Energy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 9.

Constellation Energy: Buy or sell? Read more here...

Tags: Constellation Energy
Kennethcix

Kennethcix

Related Posts

Fujikura Stock
AI & Quantum Computing

Fujikura’s Rebound Puts CEO Reassurance and a $73 Billion Fiber Forecast in the Spotlight

July 9, 2026
Vulcan Energy Stock
Automotive & E-Mobility

State Street Ups Stake in Vulcan Energy as Shares Tumble to New 52-Week Low

July 9, 2026
Nokia Stock
AI & Quantum Computing

Nokia’s €100 Million Defense Bet Highlights New Revenue Streams as Shares Sit 30% Below Their Peak

July 9, 2026
Next Post
TSMC Stock

TSMC Wins AA- Upgrade and Shifts to Dollar Dividends as AI Chip Demand Tightens Its Grip

WisdomTree Silver 3x Daily Leveraged Stock

Triple-Leveraged Silver ETF Swing Sends Mixed Signals as Safe-Haven Bid Runs into Rate-Fed Headwinds

Ocugen Stock

Ocugen’s Modifier Gene Therapy Targets Dozens of Blindness-Causing Mutations with One Drug

Recommended

MicroStrategy Stock

Strategy’s Dual Focus Faces Market Scrutiny as Bitcoin Bet Weighs on Shares

9 months ago
Twilio Stock

Twilio Stock: Is the Cloud Giant Regaining Its Footing?

8 months ago
Amazon Stock

Amazon’s Strategic Pivot: Record Performance Amid Workforce Restructuring

8 months ago
Silber Preis Stock

Silver Market Faces Structural Supply Crisis

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen’s Modifier Gene Therapy Targets Dozens of Blindness-Causing Mutations with One Drug

Triple-Leveraged Silver ETF Swing Sends Mixed Signals as Safe-Haven Bid Runs into Rate-Fed Headwinds

TSMC Wins AA- Upgrade and Shifts to Dollar Dividends as AI Chip Demand Tightens Its Grip

Constellation Energy: A 32% Stock Slide Masks Record Revenue and a Nuclear-Led Strategy

Ondas Holdings: A Six-Month Lock-Up Window to Validate the DZYNE Bet

Hard Assets Rule: Energy, Defense, and Chips Cash In on Hormuz

Trending

TKMS Stock
Defense & Aerospace

TKMS Shares Swing From Gains to Losses After Bundestag Approves €6.3B Frigate Program

by Rodolfo Hanigan
July 9, 2026
0

TKMS shares staged a dramatic intraday reversal on Thursday, climbing in early trade after the Bundestag’s budget...

Vincorion Stock

Vincorion’s Two-Day Shift: A NATO Rally Wipes Out an IPO-Driven Slide

July 9, 2026
Fujikura Stock

Fujikura’s Rebound Puts CEO Reassurance and a $73 Billion Fiber Forecast in the Spotlight

July 9, 2026
Ocugen Stock

Ocugen’s Modifier Gene Therapy Targets Dozens of Blindness-Causing Mutations with One Drug

July 9, 2026
WisdomTree Silver 3x Daily Leveraged Stock

Triple-Leveraged Silver ETF Swing Sends Mixed Signals as Safe-Haven Bid Runs into Rate-Fed Headwinds

July 9, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • TKMS Shares Swing From Gains to Losses After Bundestag Approves €6.3B Frigate Program
  • Vincorion’s Two-Day Shift: A NATO Rally Wipes Out an IPO-Driven Slide
  • Fujikura’s Rebound Puts CEO Reassurance and a $73 Billion Fiber Forecast in the Spotlight

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com